Home Cart 0 Sign in  
X

[ CAS No. 81926-24-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 81926-24-1
Chemical Structure| 81926-24-1
Chemical Structure| 81926-24-1
Structure of 81926-24-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 81926-24-1 ]

Related Doc. of [ 81926-24-1 ]

Alternatived Products of [ 81926-24-1 ]

Product Details of [ 81926-24-1 ]

CAS No. :81926-24-1 MDL No. :MFCD08436969
Formula : C10H10O2 Boiling Point : -
Linear Structure Formula :- InChI Key :YQBBCPKSALSCAP-UHFFFAOYSA-N
M.W : 162.19 Pubchem ID :10986562
Synonyms :

Calculated chemistry of [ 81926-24-1 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.4
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 45.13
TPSA : 18.46 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.92 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.2
Log Po/w (XLOGP3) : 1.93
Log Po/w (WLOGP) : 1.56
Log Po/w (MLOGP) : 1.71
Log Po/w (SILICOS-IT) : 3.1
Consensus Log Po/w : 2.1

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.43
Solubility : 0.601 mg/ml ; 0.0037 mol/l
Class : Soluble
Log S (Ali) : -1.94
Solubility : 1.86 mg/ml ; 0.0114 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.97
Solubility : 0.174 mg/ml ; 0.00107 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.79

Safety of [ 81926-24-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 81926-24-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 81926-24-1 ]
  • Downstream synthetic route of [ 81926-24-1 ]

[ 81926-24-1 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 178557-12-5 ]
  • [ 81926-24-1 ]
YieldReaction ConditionsOperation in experiment
80% With n-butyllithium In tetrahydrofuran; hexane at 0℃; for 0.166667 h; Inert atmosphere A solution of 10.50 g (26.6 mmol) of the dibromo bis-ether 3 in 250 mL of dry THF was placed in a N2 atmosphere and cooled to 0 °C. A solution of 2.5 M n-butyllithium in hexanes (23.52 mL, 2.2 equiv) was added very quickly (addition time: 7 s) to the rapidly stirred solution using a syringe with a large gauge needle. The reaction mixture was stirred for 10 min, and solvent was removed in vacuo. The residue was partitioned between EtOAc and H2O, and the organic phase was dried with Na2SO4 and evaporated to furnish the crude product, which was chromatographed on silica gel (petroleum ether 60-90 °C : ethyl acetate = 20:1) to afford the products 4 (3.47 g, 80percent) as white crystals. Yield 80percent. White solid. 1H NMR (300 MHz, CDCl3) δ: 6.63 (2H, s), 4.52 (4H, t, J = 8.6 Hz), 3.13 (4H, t, J = 8.5 Hz). 13C NMR (75 MHz, CDCl3) δ : 154.12 (C), 125.93 (C), 105.88 (CH), 71.51 (CH2), 30.31 (CH2).
Reference: [1] Journal of Medicinal Chemistry, 1996, vol. 39, # 15, p. 2953 - 2961
[2] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 8, p. 1808 - 1814
[3] Journal of Medicinal Chemistry, 2001, vol. 44, # 6, p. 1003 - 1010
  • 2
  • [ 37142-37-3 ]
  • [ 81926-24-1 ]
Reference: [1] Journal of Medicinal Chemistry, 2001, vol. 44, # 6, p. 1003 - 1010
[2] Journal of Medicinal Chemistry, 1996, vol. 39, # 15, p. 2953 - 2961
[3] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 8, p. 1808 - 1814
  • 3
  • [ 104-38-1 ]
  • [ 81926-24-1 ]
Reference: [1] Journal of Medicinal Chemistry, 2001, vol. 44, # 6, p. 1003 - 1010
  • 4
  • [ 1774-47-6 ]
  • [ 81926-14-9 ]
  • [ 81926-24-1 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1982, p. 841 - 848
  • 5
  • [ 6339-48-6 ]
  • [ 81926-24-1 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1982, p. 841 - 848
  • 6
  • [ 123-31-9 ]
  • [ 81926-24-1 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 8, p. 1808 - 1814
Same Skeleton Products
Historical Records

Related Parent Nucleus of
[ 81926-24-1 ]

Other Aromatic Heterocycles

Chemical Structure| 1616526-84-1

[ 1616526-84-1 ]

5-Methoxychroman-4-ol

Similarity: 0.81

Chemical Structure| 10191-41-0

[ 10191-41-0 ]

2,5,7,8-Tetramethyl-2-(4,8,12-trimethyltridecyl)chroman-6-ol

Similarity: 0.81

Chemical Structure| 94105-90-5

[ 94105-90-5 ]

3-(4-Hydroxyphenyl)chroman-7-ol

Similarity: 0.80

Chemical Structure| 92-83-1

[ 92-83-1 ]

9H-Xanthene

Similarity: 0.80

Chemical Structure| 955959-84-9

[ 955959-84-9 ]

4-(4-Bromophenyl)dibenzo[b,d]furan

Similarity: 0.77